Article ; Online: Overuse of long-acting β
2024 Volume 135, Issue 8, Page(s) 784–802
Abstract: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality globally. In the major revision of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report, the scientific committee concluded that ...
Abstract | Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality globally. In the major revision of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 report, the scientific committee concluded that the use of long-acting β |
---|---|
MeSH term(s) | Humans ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Muscarinic Antagonists/therapeutic use ; Administration, Inhalation ; Drug Therapy, Combination ; Adrenal Cortex Hormones/therapeutic use ; Dyspnea/chemically induced ; Dyspnea/drug therapy ; Bronchodilator Agents/therapeutic use |
Chemical Substances | Adrenergic beta-2 Receptor Agonists ; Muscarinic Antagonists ; Adrenal Cortex Hormones ; Bronchodilator Agents |
Language | English |
Publishing date | 2024-01-10 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 410138-8 |
ISSN | 1941-9260 ; 0032-5481 |
ISSN (online) | 1941-9260 |
ISSN | 0032-5481 |
DOI | 10.1080/00325481.2023.2284650 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.407: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.